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Objective: To evaluate the psychosocial implications of newborn screening for Duchenne muscular
dystrophy.
Design: Prospective psychosocial assessment.
Setting: Primary care.
Respondents: Study: (a) families of an affected boy identified by screening (n = 20); (b) families of a
boy with a transient screening abnormality (n = 18). Control: (a) families of a boy with a later clinical
diagnosis (n = 16); (b) random sample of mothers of boys aged 6–9 months (n = 43).
Interventions: Questionnaires and semistructured interviews.
Main outcome measures: Attitudes to newborn screening and impact of screening on mother-baby
relationship, anxiety/wellbeing, and reproductive patterning within families of an affected boy.
Results: Most families of an affected boy were in favour of newborn screening on the grounds of
reproductive choice and time to prepare emotionally and practically. There was no evidence of any
long term disruption to the mother-baby relationship. Anxiety levels for the screened group were slightly
above threshold but returned to normal during the period of the study. There was no evidence, from
anxiety or wellbeing scores, that the transient group had suffered any disadvantage. Although the pro-
file of the screened and later clinically diagnosed cohorts was similar after diagnosis, when boys from
the screened cohort were 4 years old and more socially aware, their profile was more positive. There
was evidence that reproductive patterning had been modified, and four fetuses carrying a mutation
causing Duchenne muscular dystrophy were terminated.
Conclusion: A case can be made for newborn screening provided that the test is optional, a rigorous
protocol for service delivery is used, and an infrastructure providing continuing support is in place.
Duchenne muscular dystrophy (DMD) is a lethal geneticdisease which is traditionally diagnosed symptomati-cally, the mean age of detection being between 4 and 5
years.1–3 It has been recognised that this diagnostic process has
two major disadvantages: firstly, it is often prolonged2 4 with
no evidence of any improvement over the past 20 years,5 and
secondly, further affected boys may be born before the
diagnosis is made.1 2 Two alternative methods of earlier
diagnosis have been proposed. The first is to screen boys at 18
months.6 This approach only provides reproductive choice
after 18 months and is difficult to implement at the primary
healthcare level.7 The second method is to screen boys in the
newborn period. Newborn screening became feasible in 1975
with the development of an assay for creatine kinase in dried
blood samples,8 but, although several centres undertake
screening,9 it is still highly controversial. It has been argued
that choice in future pregnancies does not outweigh the
potential disadvantages of screening for an untreatable
disease. In particular, health professionals have been con-
cerned about any effect on the early mother-baby
relationship,10 11 although these concerns have not been
substantiated by research based evidence.
We report a long term psychosocial follow up of families
identified during a newborn screening programme for DMD.
We examine the advantages and disadvantages experienced
by families with an affected boy and those whose boy had a
transient abnormality—that is, a raised creatine kinase activ-
ity on screening but a normal level in a venous blood sample
at 6 weeks of age.
The research took place between July 1990 andMarch 1998.
On the basis of the evidence provided to the health authorities
in Wales, newborn screening has been funded since April
1998. Details of the laboratory process, the protocol developed
for service delivery, and the attitude of health professionals
and families who opted out of screening have been reported
elsewhere.9 12–14
METHODS
In 1990 an “opt in” newborn screening programme for DMD
was introduced inWales to evaluate the feasibility of screening
and to assess the psychosocial implications of such an early
diagnosis. Parents were given information (verbally and in
writing) about each of the diseases screened for in the
newborn period and the management and treatment available
for them. In the case of the DMD test, the information leaflet
stated that it was an extra test that parents could choose to
have and that there was no cure for the disease.
During the eight year research period, 139 796 samples
from boys were received in the laboratory, and 7531 (5.4%)
families declined the DMD test. The parents’ decision was not
recorded by the midwife in a further 3171 (2.3%) cases. The
remaining 129 094 boys were tested (uptake rate of 92.3%).
There were 43 abnormal screening results; 22 abnormal tests
(1:5867) were confirmed on a subsequent venous blood sam-
ple. Of these 22 confirmed cases, two families were not
approached because they had a known family history of DMD,
while the remaining 20 families were invited and agreed to
join the psychosocial research. These boys have all been
confirmed as having DMD, either by muscle biopsy or a com-
bination of mutation analysis and clinical symptoms. There
were 15 families whose sons had reached 4 years of age by the
end of the research, all of whom took part in the second inter-
view.
To assess the implications of newborn screening, we
collected data from four populations.
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Study populations
Families of an affected boy identified by screening
(screened cohort n = 20)
Case studies were constructed for each family from the time of
the screening test to the boy’s 4th birthday. There were four
main data sources: (a) questionnaire and semistructured
interview with the family at 9 months of age (first interview);
(b) informal home visits by the researcher at 2 and 3 years of
age; (c) questionnaire and semistructured interview with the
family when the boy was 4 years old (second interview); (d) a
questionnaire completed by the family’s health visitor during
the first six months. Further details of the research methods
have been published elsewhere.15
Families of a boy with a transient screening abnormality
(transient cohort n = 18)
Data were collected from one semistructured interview and
questionnaire two to three months after the normal result had
been given. There were 21 transient abnormalities (1:6147),
with three families not being contacted because resampling
had already been performed as part of continuing medical
interventions. The remaining 18 families agreed to join the
study.
Families of a boy who experienced a later clinical
diagnosis (later clinically diagnosed cohort n = 16)
A group of families fromWales and the SouthWest of England
were interviewed and completed a questionnaire in the year
after diagnosis. This group was used as a control for the
screened cohort.
The mean (SE) age of diagnosis for this cohort was 50 (6.4)
months (range 18–101), with mothers reporting a mean (SE)
delay of 23 (4.3) months (range 1–48) between raising their
concerns with a health professional and diagnosis.
A control group from the general population (general
population cohort n = 43)
A random sample of mothers with baby boys aged 6–9 months
(n = 108) drawn from newborn screening records were
invited to complete a postal questionnaire. A total of 43 ques-
tionnaires were returned (40% response rate). This cohort
provided control data for the screened and transient cohort
with boys aged 6–9 months.
Measures
Attitudes to screening
A structured question was asked with the options: in favour,
against, or undecided. These data were collected from all
cohorts except the general population. In addition, during the
interview, mothers from the transient cohort were asked
whether they had any lingering doubts about the normal test
result and whether they would permit screening of another
baby for DMD.
Mother-baby relationship
Three measures were used to assess the relationship.
(1) FIRST score: assessments made by health visitor of moth-
er’s responses to baby on five dimensions: feeding, interest,
response, speech, and touch.16 Responses were assessed before
the query about DMD was raised, immediately after, and one
month later. Each dimension was scored from 0 to 2 giving a
cumulative score ranging from 0 to 10. These data were
collected from the screened and transient cohorts.
(2) Rejection/protection index: mothers were asked to score
five statements, one of which explored potential rejection (“I
feel I want to run away and leave him”), and the others
explored potential overprotection—for example, feeling pro-
tective,wanting to hug,watching closely, and not trusting him
with others. Each statement was scored 1 (strongly disagree)
to 5 (strongly agree). These data were collected from all
cohorts.
(3) Baby/child adjectives: Green et al17 have argued that an
adjective checklist is a useful tool to evoke mothers’
descriptions of their babies. Mothers were given a list of 20
adjectives and asked to select as many as they thought
described their son. The adjectives were: doing well, healthy,
strong, frail, little, contented, placid, good, responsive, alert,
demanding, difficult, miserable, fretful, great, lovely, fun, cud-
dly, handful, exhausting. These data were collected from all
cohorts.
Anxiety and wellbeing
Mothers completed the six item short form of the State
scale,18 19 which has a range of 6–24 with a normal range of
9–12. These data were collected from all cohorts except the
general population. The General Health Questionnaire (GHQ)
1220 has a range of 0–12 with a normal threshold of 2–3. These
data were collected from all cohorts.
Reproductive patterning
Details of the subsequent reported reproductive patterning of
the screened cohort and their extended family were collected.
Statistical analysis
Data were analysed using SSPS for Windows version 10. Statis-
tical analysis was carried out using Kruskal-Wallis analysis of
variance, t test, Mann-Whitney, Wilcoxon, and Fisher’s tests as
appropriate. Indications of the impact of multiple comparisons
are given where appropriate using the Bonferroni correction.
RESULTS
Attitudes to screening
Table 1 shows attitudes to screening for the screened,
transient, and later clinically diagnosed cohorts.
Screened cohort (n = 20)
Families gave two main reasons for favouring newborn
screening: reproductive choice and time to come to terms with
the diagnosis before their son was aware, to plan housing and
schooling, begin early physiotherapy, and make good memo-
ries. During their interviews, the two families who had
marked their questionnaires “undecided” described how
ambivalent they were, one minute in favour of screening, the
next against. The family who were opposed to screening felt
that they had not been given sufficient information and
regretted the earlier diagnosis.
Transient cohort (n = 18)
The one mother against screening said she had regretted hav-
ing the test and would have refused it had she realised that the
disease was untreatable. This mother, and two others, said
they would not allow testing of another baby. Two other
mothers expressed some doubts about the normal result; for
Table 1 Attitudes to screening of the screened,
transient, and later traditionally diagnosed cohorts
Screened
1st
interview
(n=20)
Transient
(n=18)
Screened
2nd
interview
(n=15)
Later
clinically
diagnosed
(n=16)
In favour 17 (85%) 16 (89%) 13 (87%) 14 (88%)
Against 1 (5%) 1 (5.5%) 1 (6%)
Undecided 2 (10%) 1 (5.5%) 2 (13%) 1 (6%)
Total 20 (100%) 18 (100%) 15 (100%) 16 (100%)
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one these concerns were understandable because a non-
familial relative had an affected son. Both mothers were in
favour of screening and would have another baby tested.
Later clinically diagnosed cohort (n = 16)
Of the 16 families in this cohort, 14 said that they would have
preferred newborn screening. There were four main reasons:
the ability to plan for the future, earlier physiotherapy, to avoid
diagnostic delay, and avoid misunderstanding their son’s early
symptoms. Several mothers felt that they would have coped
better knowing when he was younger: one said “not knowing,
you are just in a fool’s paradise”. One mother was against and
one was undecided because, had she gone on to have a second
affected boy, she would have been in favour.
Mother-baby relationship
FIRST scores
Table 2 shows the median scores and ranges for the screened
and transient cohorts. There was only one case (screened
cohort) where the health visitor noted a short term change in
baby handling, with his mother not as free in handing the
baby to visitors. One month after the query, all scores had
either returned to the initial level or increased.
A significant increase was noted (Wilcoxon) for both
cohorts in the scores one month after the query compared
with those before the query (screened group, z = 2.53,
p < 0.05*; transient group, z = 2.71, p < 0.01*) and immedi-
ately after the query (screened group, z = 2.13, p < 0.05;
transient group, z = 2.53, p < 0.05*) (* indicates that signifi-
cance was retained after Bonferroni correction).
Rejection/protection statements
No significant difference was found between any of the
cohorts on the statement about feelings of “wanting to run
away” (t test, Wilcoxon, and Mann-Whitney). There were no
mothers in the screened or transient cohort who agreed or
strongly agreed with the statement, whereas there were three
mothers in the general population cohort who did. For boys
aged 6–9 months, a Kruskal-Wallis analysis of variance (non-
parametric) found no differences between the three cohorts
on any of the protection statements. Similarly the Mann-
Whitney test found no differences between the screened
group (second interview) and the later clinically diagnosed
cohort when the boys were 4 years or older. There was,
however, a significant difference found on the “watch”
statement between first (3.3) and second (4.2) interview for
the screened cohort (z = 2.48, p < 0.05; Wilcoxon) and
between the first (3.3) interview and later clinically diagnosed
cohort (4.3) (z = 2.64, p < 0.05;Mann-Whitney), but none of
these remained significant after Bonferroni’s correction for
multiple comparisons.
Baby/child adjectives
We analysed the frequency with which a particular adjective
was chosen to describe their son by one cohort compared with
another.We found no between cohort differences on any of the
seven negative descriptors: frail, little, miserable, fretful,
exhausting, difficult, or demanding or on four of the positive
descriptors: contented, placid, good, or lovely. Tables 3 and 4
show usage of the remaining nine descriptors. Mothers from
the screened and transient cohort, with boys aged 6–9 months
old, were less likely than mothers in the general population to
choose doing well, alert, great, fun, and handful. They were,
however, more likely to choose cuddly. There were three
changes over time noted for the screened cohort (Wilcoxon),
with mothers by second interview more likely to choose doing
well (z = 2.24, p < 0.05), fun (z = 2.65, p < 0.01), and hand-
ful (z = 2.83, p < 0.01). The later clinically diagnosed cohort
scored lower on all nine positive adjectives than the screened
cohort (second interview). Differences on responsive and
great were individually significant but did not remain after
Bonferroni’s correction for multiple comparisons.
Anxiety and wellbeing
A one way analysis of variance comparison showed no signifi-
cant between cohort differences on either the anxiety or the
wellbeing measure, although levels of anxiety in the screened
cohort at 6–9 months of age (13.7) and later clinically
diagnosed cohort at 4 years or older (13.1) were slightly above
the normal threshold. The GHQ scores for all mothers with
boys 6–9 months old were slightly above threshold, as were
those for the later clinically diagnosed cohort.
Reproductive patterning
The index and extended families, from the screened cohort,
notified the Institute of Medical Genetics about 27 subsequent
pregnancies. There were four social terminations, the relation
of which to the diagnosis is unclear, and 19 of the remaining
23 (83%) were tested or identified as being at minimal risk.
The outcome of these 19 pregnancies was: seven healthy boys,
Table 2 FIRST scores for screened and transient
cohorts
Before query After query
One month
later
Screened (n=18) 10 (8–10) 10 (8–10) 10 (9–10)
Transient (n=13) 9 (7–10) 9 (7–10) 10 (9–10)
Values are median (range).
FIRST, Feeding, interest, response, speech, and touch.
Table 3 Baby adjectives used by mothers of boys
6–9 months old
Adjective
General
population
(n=43)
Screened and
transient (n=27)
p Value
(Fisher’s)
Doing well 38 (88) 17 (63) 0.02
Healthy 37 (86) 23 (85) 1.00
Strong 37 (86) 20 (74) NS
Responsive 35 (81) 23 (85) NS
Alert 41 (95) 20 (74) 0.02
Great 37 (86) 12 (44) <0.001*
Fun 41 (95) 14 (52) <0.001*
Cuddly 27 (63) 25 (93) 0.005*
Handful 20 (47) 3 (11) 0.003*
Values in parentheses are percentages. Note: the screened cohort 1st
interview and the transient cohort have been combined because of
small numbers.
*Remain significant after Bonferroni’s correction for multiple
comparisons.
Table 4 Child adjectives used by mothers of boys 4
years or older
Adjective
Screened (2nd
interview)
(n=15)
Later clinically
diagnosed
(n=16)
p Value*
(Fisher’s)
Doing well 14 (93) 13 (81) NS
Healthy 8 (53) 7 (44) NS
Strong 8 (53) 5 (31) NS
Responsive 10 (67) 4 (25) 0.03
Alert 11 (73) 7 (44) NS
Great 11 (73) 5 (31) 0.03
Fun 15 (100) 12 (75) NS
Handful 6 (40) 3 (19) NS
*None of these remain significant after Bonferroni’s correction for
multiple comparisons.
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seven healthy girls, the termination of four fetuses carrying
the DMD-causing mutation, and one termination because of a
chromosomal abnormality.
Sixteen of the 20 index families (80%) reported that their
reproductive patterning had changed as a result of the
diagnosis. Fifteen of these 16 families had wanted more chil-
dren but, after diagnosis, four decided against another
pregnancy and 11 delayed. This delay is reflected in the birth
interval: the mean interval for the screened cohort between
first and second pregnancy was 41 months compared with 29
months for mothers in the general population.21 We cannot
quantify how many affected boys might have been born to
these 15 mothers, 10 of whom were high risk or obligate car-
riers, which illustrates the difficulty of using altered reproduc-
tive planning as an outcome measure.
Before diagnosis, 10 siblings were born to the later clinically
diagnosed cohort (five unaffected boys, five girls), the
unaffected boys all being born to women at low risk. The later
clinically diagnosed cohort would have included two families
with second affected children, but these were excluded
because a younger brother had been diagnosed (first), through
newborn screening.
DISCUSSION
Eventual diagnosis is inevitable for families who have a boy
with DMD. The purpose of our study was to identify the
advantages and disadvantages of it being made in the
newborn period (tables 5 and 6).
We have shown that most families modified their reproduc-
tive plans and had prenatal testing. This finding is very differ-
ent from that reported by Hildes et al22 and could reflect the
integrated service that is provided in Wales. In addition, most
of those in the screened and later clinically diagnosed cohorts
were in favour of earlier diagnosis on the grounds of gaining
time to prepare emotionally and practically. Mothers from the
later clinically diagnosed cohort perceived the advantage of
avoiding diagnostic delay and expressed their regret about
misunderstanding their son’s early symptoms.
The profile of the screened cohort (first interview) and the
later clinically diagnosed cohort is similar in terms of
increased anxiety levels, reduced wellbeing scores, and more
negative choice of descriptors. By the second interview, when
boys from the screened cohort were more socially aware of
their problem, maternal anxiety and wellbeing had returned
to normal and descriptors weremore positive than for the later
clinically diagnosed cohort. Some mothers from both groups
saw this difference as an advantage as they felt it was better to
have faced the diagnosis when he was younger than learn
about it when he was symptomatic and asking questions.
The case for newborn screening must take into account
whether there are evident disadvantages that might outweigh
these advantages. One potential disadvantage is decision
regret after the test, which occurred in two cases (one each in
the screened and transient cohorts), where informed consent
to screening had not been optimal. We have addressed this
issue recently.23 The study also highlighted the potential
disadvantage of lingering doubts about the test result by those
in the transient cohort. Our information leaflet is now more
explicit about the occurrence of transient results, and the pro-
tocol recommends that each family is given a written record of
venous blood creatine kinase levels, compared with potential
levels in DMD, and health visitors are made more aware that
lingering doubts may occur.
Concerns about the negative effect of newborn screening on
the early mother-baby relationship have not been substanti-
ated. We found no evidence, from either health visitor assess-
ments (FIRST scores) or mothers’ responses to the rejection/
protection index of rejection. There was also no evidence of
any difference during the first year of life on any of the over-
protection scores.
The analysis of baby descriptors has shown that there was
no between cohort difference in usage of the negative descrip-
tors by mothers of boys aged 6–9 months. The mothers in the
screened and transient cohorts, however, were less likely to
use certain positive descriptors and more likely to choose
“cuddly”. It is debatable whether this can be classified as a
disadvantage because there was no evidence of rejection or
overprotection on other measures. The qualitative accounts
indicate that after diagnosis, mothers in the screened group
felt that their sons had become “more precious”. Therefore,we
argue that this measure is very sensitive and has highlighted
an important qualitative change in the mother-baby relation-
ship.
We found evidence of slightly increased anxiety in both the
screened and later clinically diagnosed cohorts in the year
after diagnosis, but scores for the screened cohort were within
the normal range by second interview. There was no evidence
from anxiety scores that the transient cohort had suffered any
disadvantage, and their wellbeing was in line with the control
group, as was that of the screened cohort.
Conclusion
We have provided unique prospective data from families and
health professionals on the psychosocial implications of new-
born screening for DMD. On the basis of this evidence, we
argue that a case can be made for newborn screening, subject
to four conditions:
(1) The screening test must only be offered on the basis of
informed parental choice.
(2) The programme should be accompanied by a rigorous pro-
tocol that details how the initial query is to be raised and
ensures that there is continuing support for all identified
families.
Table 5 Potential advantages of a newborn
screening diagnosis
1. Reproductive choice
Counselling/prenatal testing 19/23
Changed intentions 16/20
2. Time
To prepare emotionally when son is less aware 17/20
To plan housing, schooling etc. 17/20
For physiotherapy 17/20
To make good memories 17/20
3. Avoid diagnostic delay Yes
4. Avoid wrongful attributions to early symptoms Yes
5. More positive profile (anxiety, wellbeing,
adjectives) when boys are socially aware
Yes
Table 6 Potential disadvantages of newborn
screening
Screened Transient
1. Decision regret after test 1/20 1/18
2. Lingering doubts about test result N/A 2/18
3. Mother-baby relationship
FIRST scores No No
Reject statement No No
Protect statements (protect/watch/trust/hugs) No No
Use of baby adjectives Change
noted
Change
noted
4. Increased anxiety (State) Slight No
5. Reduced wellbeing (GHQ 12) No No
GHQ, General Health Questionnaire.
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(3) An infrastructure should be established that ensures com-
munication and cooperation between primary, secondary, and
tertiary support services, in particular an integrated genetic
counselling service, a paediatric support service, and a desig-
nated person in newborn screening responsible for coordina-
tion.
(4) There is regular feedback from families and primary
healthcare teams to ensure that the programme is being
delivered in an acceptable way.
In view of recent concerns about the persisting late diagno-
sis of DMD, we believe it is now the time for other centres to
review our evidence and consider introducing newborn
screening for DMD.
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